Kelly R. Magliocca
Kelly R. Magliocca has a total of 171 co-authors. Here are the top co-authors by number of shared publications:
- Akinyele Olumuyiwa Adisa
University of Ibadan
4 shared publications - Elizabeth Ann Bilodeau
Members of an International Consortium on Odontogenic Tumours
4 shared publications - Haizal Mohd Hussaini
University of Otago
4 shared publications - Jonathan Jay Beitler
Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia
4 shared publications - Keith David Hunter
Liverpool Head and Neck Centre, Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
4 shared publications - Liam Robinson
Department of Oral and Maxillofacial Pathology, School of Dentistry University of Pretoria Pretoria South Africa
4 shared publications
Latest Publications
- 1 September 2026
- Published by Elsevier in Seminars in Diagnostic Pathology
Macroscopic dissection of mandibular resection specimens for odontogenic tumors
- 1 September 2026
- Published by Elsevier in Seminars in Diagnostic Pathology
Macroscopic dissection of mandibular resection specimens for odontogenic tumors
- 2 January 2026
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 55 (5) , 511-519
Papilliferous Keratoameloblastoma (PKA): Is It a Different Clinicopathological Entity or Histological Subtype of Conventional Ameloblastoma?
Background: Papilliferous keratoameloblastoma (PKA) is an exceptionally rare variant of conventional ameloblastoma, marked by papilliferous epithelial projections and prominent keratinization within an ameloblastomatous framework. Because of its rarity and overlap with other keratinizing odontogenic tumours, PKA is often overlooked and is not recognised in the current WHO classification. Limited awareness and inconsistent terminology contribute to diagnostic uncertainty and may affect clinical management. Objectives: This review critically analysed all published PKA cases to describe their clinical, radiographic and histopathological features, evaluating whether PKA should be regarded as a distinct clinicopathological entity or a histological subtype of conventional ameloblastoma. Materials and Methods: A comprehensive search of PubMed, Scopus, Web of Science, and Google Scholar was performed to identify all English‐language reports of PKA. Extracted data included demographics, clinical presentation, radiographic findings, histopathology, treatment and outcomes. The information was synthesised and descriptively analysed. Results: Seven cases of PKA were included. Patients ranged from 18 to 76 years (mean age: 50.4 years), with a male predominance. All lesions involved the right mandible. Clinically, most patients presented with slow‐growing mandibular swellings, occasionally accompanied by pain or mucosal changes. Radiographs most often show multilocular radiolucencies with buccolingual expansion or cortical perforation. Histopathology consistently reveals classic ameloblastomatous epithelium with squamous metaplasia, keratin pearl formation, and distinctive papilliferous projections lining cystic spaces. Conclusion: The uniform histopathological pattern observed across reported cases supports recognising PKA as a distinct histopathological subtype of conventional ameloblastoma. Its formal inclusion in odontogenic tumour classification appears justified, although further molecular and clinicopathological studies are needed to better define its biological behaviour.
- 2 January 2026
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 55 (5) , 511-519
Papilliferous Keratoameloblastoma (PKA): Is It a Different Clinicopathological Entity or Histological Subtype of Conventional Ameloblastoma?
Background: Papilliferous keratoameloblastoma (PKA) is an exceptionally rare variant of conventional ameloblastoma, marked by papilliferous epithelial projections and prominent keratinization within an ameloblastomatous framework. Because of its rarity and overlap with other keratinizing odontogenic tumours, PKA is often overlooked and is not recognised in the current WHO classification. Limited awareness and inconsistent terminology contribute to diagnostic uncertainty and may affect clinical management. Objectives: This review critically analysed all published PKA cases to describe their clinical, radiographic and histopathological features, evaluating whether PKA should be regarded as a distinct clinicopathological entity or a histological subtype of conventional ameloblastoma. Materials and Methods: A comprehensive search of PubMed, Scopus, Web of Science, and Google Scholar was performed to identify all English‐language reports of PKA. Extracted data included demographics, clinical presentation, radiographic findings, histopathology, treatment and outcomes. The information was synthesised and descriptively analysed. Results: Seven cases of PKA were included. Patients ranged from 18 to 76 years (mean age: 50.4 years), with a male predominance. All lesions involved the right mandible. Clinically, most patients presented with slow‐growing mandibular swellings, occasionally accompanied by pain or mucosal changes. Radiographs most often show multilocular radiolucencies with buccolingual expansion or cortical perforation. Histopathology consistently reveals classic ameloblastomatous epithelium with squamous metaplasia, keratin pearl formation, and distinctive papilliferous projections lining cystic spaces. Conclusion: The uniform histopathological pattern observed across reported cases supports recognising PKA as a distinct histopathological subtype of conventional ameloblastoma. Its formal inclusion in odontogenic tumour classification appears justified, although further molecular and clinicopathological studies are needed to better define its biological behaviour.
- 2 July 2025
- Published by Springer Nature in Virchows Archiv
- Vol. 487 (2) , 401-411
Histologic characteristics and predictors of outcome in epithelial-myoepithelial carcinoma (EMC) of salivary gland: a multi-center study of 75 cases
Epithelial-myoepithelial carcinoma (EMC) may occur de novo or ex pleomorphic adenoma (PA). We aimed to investigate the prognostic and clinicopathologic features and the utility of RAS Q61R immunohistochemistry in a multicenter retrospective cohort of 75 EMCs. Seven tumors (9%) were EMC ex PA, whereas 91% (n = 68) were EMC de novo. Compared with EMC de novo, EMC ex PA was associated with a significant higher percentage of hyalinized and myxoid stroma, larger tumor size, frequent perineural invasion (PNI), absence of nuclear enlargement, and lower frequency of pT1 disease. Seven out of 65 patients had adverse events (five local recurrence, two regional recurrences, two distant metastases, and two disease-related death). The 5-year and 10-year disease-specific survival were 100% and 91% respectively, and the 5-year and 10-year disease-free survival (DFS) were 90% and 85% respectively. Adverse pathologic features that were associated with RFS on univariate survival analysis included PNI, atypical mitosis, mitotic count, and tumor size ≥ 4 cm. Among them, PNI and atypical mitosis remained as independent prognostic factors on multivariate survival analysis. The frequency of RAS Q61R immunopositivity was 31% (12/39) in EMC de novo, 0% (0/5) in EMC ex PA, and 0% (0/32) in non-EMC salivary neoplasms. In conclusion, although most of the EMCs are de novo, 9% are EMCs ex PA. PNI, mitotic index, atypical mitosis, and large tumor size predict shortened RFS in EMC. RAS Q61R immunopositivity is highly specific for EMC de novo and is absent in EMC ex PA.
- 2 July 2025
- Published by Springer Nature in Virchows Archiv
- Vol. 487 (2) , 401-411
Histologic characteristics and predictors of outcome in epithelial-myoepithelial carcinoma (EMC) of salivary gland: a multi-center study of 75 cases
Epithelial-myoepithelial carcinoma (EMC) may occur de novo or ex pleomorphic adenoma (PA). We aimed to investigate the prognostic and clinicopathologic features and the utility of RAS Q61R immunohistochemistry in a multicenter retrospective cohort of 75 EMCs. Seven tumors (9%) were EMC ex PA, whereas 91% (n = 68) were EMC de novo. Compared with EMC de novo, EMC ex PA was associated with a significant higher percentage of hyalinized and myxoid stroma, larger tumor size, frequent perineural invasion (PNI), absence of nuclear enlargement, and lower frequency of pT1 disease. Seven out of 65 patients had adverse events (five local recurrence, two regional recurrences, two distant metastases, and two disease-related death). The 5-year and 10-year disease-specific survival were 100% and 91% respectively, and the 5-year and 10-year disease-free survival (DFS) were 90% and 85% respectively. Adverse pathologic features that were associated with RFS on univariate survival analysis included PNI, atypical mitosis, mitotic count, and tumor size ≥ 4 cm. Among them, PNI and atypical mitosis remained as independent prognostic factors on multivariate survival analysis. The frequency of RAS Q61R immunopositivity was 31% (12/39) in EMC de novo, 0% (0/5) in EMC ex PA, and 0% (0/32) in non-EMC salivary neoplasms. In conclusion, although most of the EMCs are de novo, 9% are EMCs ex PA. PNI, mitotic index, atypical mitosis, and large tumor size predict shortened RFS in EMC. RAS Q61R immunopositivity is highly specific for EMC de novo and is absent in EMC ex PA.
- 13 May 2025
- Published by Wiley in Oral Diseases
- Vol. 31 (10) , 2914-2925
Classic Desmoplastic Ameloblastoma: Should It Be a Distinct Subtype of Ameloblastoma?—Based on Clinicopathological, Radiological, Immunohistochemical and Molecular Study of a Large Cohort
Objectives: To identify whether the classic desmoplastic ameloblastoma (DA) is an independent subtype of ameloblastoma. Materials and Methods: Eighty‐six classic DA and 28 hybrid DA cases were retrieved, and available clinical, radiological, and histopathological data were collected. DNA from microdissected tumor tissues were utilized for BRAF V600E , SMOL412F , and CTNNB1 mutation detection. Data of classic DA and hybrid DA were analyzed and compared with each other and with previous reports of conventional ameloblastoma (CA). Results: 69.8% (60/86) of classic DA occurred in the mandible, with the majority affecting the anterior‐premolar regions. They were characterized as osteolytic bone expansion (33.8 ± 12.8 mm) with internal bone/calcification (57/58, 98.3%) in radiology. Genetically, classic DA exhibited a high incidence of BRAF V600E mutation (58/62, 93.5%) but no CTNNB1 and SMO L412F mutations. Hybrid DA exhibited similarities to CA in jawbone location, tumor size, and radiology. The recurrence rate of classic DA (9.2%) was lower than that of CA (25.8%). Conclusion: High anterior‐premolar distribution, a mixture of osteolytic and internal high‐density shadows in radiology, smaller tumor size, compressed epithelium with abundant stroma and scattered bone, consistent mutation of BRAF V600E , and better prognosis all suggest that classic DA may be a distinct clinicopathological subtype of ameloblastoma.
- 13 May 2025
- Published by Wiley in Oral Diseases
- Vol. 31 (10) , 2914-2925
Classic Desmoplastic Ameloblastoma: Should It Be a Distinct Subtype of Ameloblastoma?—Based on Clinicopathological, Radiological, Immunohistochemical and Molecular Study of a Large Cohort
Objectives: To identify whether the classic desmoplastic ameloblastoma (DA) is an independent subtype of ameloblastoma. Materials and Methods: Eighty‐six classic DA and 28 hybrid DA cases were retrieved, and available clinical, radiological, and histopathological data were collected. DNA from microdissected tumor tissues were utilized for BRAF V600E , SMOL412F , and CTNNB1 mutation detection. Data of classic DA and hybrid DA were analyzed and compared with each other and with previous reports of conventional ameloblastoma (CA). Results: 69.8% (60/86) of classic DA occurred in the mandible, with the majority affecting the anterior‐premolar regions. They were characterized as osteolytic bone expansion (33.8 ± 12.8 mm) with internal bone/calcification (57/58, 98.3%) in radiology. Genetically, classic DA exhibited a high incidence of BRAF V600E mutation (58/62, 93.5%) but no CTNNB1 and SMO L412F mutations. Hybrid DA exhibited similarities to CA in jawbone location, tumor size, and radiology. The recurrence rate of classic DA (9.2%) was lower than that of CA (25.8%). Conclusion: High anterior‐premolar distribution, a mixture of osteolytic and internal high‐density shadows in radiology, smaller tumor size, compressed epithelium with abundant stroma and scattered bone, consistent mutation of BRAF V600E , and better prognosis all suggest that classic DA may be a distinct clinicopathological subtype of ameloblastoma.
- 21 April 2025
- Published by Wiley in Oral Diseases
- Vol. 31 (11) , 2999-3007
Odontogenic Tumors in Pediatric and Adolescent Populations: A Scoping Review
Objective: To integrate the available data published on odontogenic tumors (OT) in the pediatric population into a comprehensive analysis. Materials and Methods: A scooping review based on the Preferred Reporting Items for Systematic Reviews and Meta‐analyses extension for scoping reviews (PRISMA‐ScR) statement was conducted. Four databases were assessed, followed by manual and gray literature searches. Case series or observational studies focused on pediatric OTs were included. The critical appraisal was conducted following the Joanna Briggs Institute tools. Results: A total of 32 articles were included, comprising 1944 OTs in individuals up to 20 years old. Benign lesions represented 99.5% of the identified tumors. In general, ameloblastoma (42.1%) was the most frequent lesion. However, when analyzing only the retrospective studies that included all types of OT (9 studies/1321 individuals), odontoma (28.8%) was more prevalent, followed by ameloblastoma (27.2%). The mean age of the individuals reported in the studies commonly was in the second decade of life. Regarding the male‐to‐female ratio, a higher incidence in males was identified in 19 articles. Conclusion: Our findings reaffirm the characteristics of OTs in this population, predominantly occurring in males in the second decade of life, demonstrating a clear predominance of benign lesions over malignant counterparts.
- 21 April 2025
- Published by Wiley in Oral Diseases
- Vol. 31 (11) , 2999-3007
Odontogenic Tumors in Pediatric and Adolescent Populations: A Scoping Review
Objective: To integrate the available data published on odontogenic tumors (OT) in the pediatric population into a comprehensive analysis. Materials and Methods: A scooping review based on the Preferred Reporting Items for Systematic Reviews and Meta‐analyses extension for scoping reviews (PRISMA‐ScR) statement was conducted. Four databases were assessed, followed by manual and gray literature searches. Case series or observational studies focused on pediatric OTs were included. The critical appraisal was conducted following the Joanna Briggs Institute tools. Results: A total of 32 articles were included, comprising 1944 OTs in individuals up to 20 years old. Benign lesions represented 99.5% of the identified tumors. In general, ameloblastoma (42.1%) was the most frequent lesion. However, when analyzing only the retrospective studies that included all types of OT (9 studies/1321 individuals), odontoma (28.8%) was more prevalent, followed by ameloblastoma (27.2%). The mean age of the individuals reported in the studies commonly was in the second decade of life. Regarding the male‐to‐female ratio, a higher incidence in males was identified in 19 articles. Conclusion: Our findings reaffirm the characteristics of OTs in this population, predominantly occurring in males in the second decade of life, demonstrating a clear predominance of benign lesions over malignant counterparts.
- 23 August 2024
- Published by Springer Nature in Head and Neck Pathology
- Vol. 18 (1) , 1-6
Tyrosine-Like Crystalloids Localize to Non-Neoplastic True Vocal Cord and Attachments
Background Tyrosine-rich or tyrosine-like crystalloids (TC) were initially described in salivary gland pleomorphic adenoma. The presence of TC in non-neoplastic tissues is rare, and it has been reported exclusively in the larynx. This study aims to characterize the frequency and anatomical localization of TC in total laryngectomy specimens. Methods Review of consecutive laryngectomy specimens in which the cassette summary documented parasagittal section sampling of the right and left vocal folds and the anterior commissure. Data collected included patient demographics, underlying diagnoses, history of radiation therapy, presence, and location of TC. Results Of 86 laryngectomy specimens, 16 (19%) contained amphophilic to eosinophilic TC. The study cohort included 11 males and 5 females, aged 37 to 85 years (mean 62, median 63). Laryngectomy surgery was performed for advanced untreated squamous cell carcinoma (SCCa) (7/16, 43.75%), recurrent post-treatment SCCa (7/16, 43.75%), previously untreated laryngeal large cell neuroendocrine carcinoma (1/16, 6.25%), and non-functional larynx post-chemoradiation (1/16, 6.25%). According to the macroscopic cassette summary, TC were predominantly found in the anterior commissure Sect. (13/16, 81.25%), with fewer cases in sections containing the left (2/16, 12.5%) or the right (1/16, 6.25%) vocal folds. Microscopically, TC localized to the anterior macula flava and/or adjacent vocal ligament (12/16, 75%) and the anterior commissure tendon (4/16, 25%). Conclusions TCs are predominantly reported as admixed with a neoplasm, however this study confirms that TC can also occur in non-neoplastic tissues of the larynx. There was no clear relationship between the presence of TC and prior radiation therapy. TC in the specialized connective tissues of the macula flava and true cord tendinous insertions distinct from tumor may form in response to alterations in mechanical stress, though an age-related change within the spectrum of normal laryngeal microanatomy also remains a possibility.
- 23 August 2024
- Published by Springer Nature in Head and Neck Pathology
- Vol. 18 (1) , 1-6
Tyrosine-Like Crystalloids Localize to Non-Neoplastic True Vocal Cord and Attachments
Background Tyrosine-rich or tyrosine-like crystalloids (TC) were initially described in salivary gland pleomorphic adenoma. The presence of TC in non-neoplastic tissues is rare, and it has been reported exclusively in the larynx. This study aims to characterize the frequency and anatomical localization of TC in total laryngectomy specimens. Methods Review of consecutive laryngectomy specimens in which the cassette summary documented parasagittal section sampling of the right and left vocal folds and the anterior commissure. Data collected included patient demographics, underlying diagnoses, history of radiation therapy, presence, and location of TC. Results Of 86 laryngectomy specimens, 16 (19%) contained amphophilic to eosinophilic TC. The study cohort included 11 males and 5 females, aged 37 to 85 years (mean 62, median 63). Laryngectomy surgery was performed for advanced untreated squamous cell carcinoma (SCCa) (7/16, 43.75%), recurrent post-treatment SCCa (7/16, 43.75%), previously untreated laryngeal large cell neuroendocrine carcinoma (1/16, 6.25%), and non-functional larynx post-chemoradiation (1/16, 6.25%). According to the macroscopic cassette summary, TC were predominantly found in the anterior commissure Sect. (13/16, 81.25%), with fewer cases in sections containing the left (2/16, 12.5%) or the right (1/16, 6.25%) vocal folds. Microscopically, TC localized to the anterior macula flava and/or adjacent vocal ligament (12/16, 75%) and the anterior commissure tendon (4/16, 25%). Conclusions TCs are predominantly reported as admixed with a neoplasm, however this study confirms that TC can also occur in non-neoplastic tissues of the larynx. There was no clear relationship between the presence of TC and prior radiation therapy. TC in the specialized connective tissues of the macula flava and true cord tendinous insertions distinct from tumor may form in response to alterations in mechanical stress, though an age-related change within the spectrum of normal laryngeal microanatomy also remains a possibility.
- 1 May 2024
- Published by Wiley in Oral Diseases
- Vol. 30 (6) , 3571-3581
Targeted therapies in ameloblastomas and ameloblastic carcinoma—A systematic review
Targeted therapy has the potential to be used in the neoadjuvant setting for odontogenic tumors, reducing the morbidities associated with major surgery. In this regard, the aim of this study was to summarize the current evidence on the different forms of targeted therapy, effectiveness, and drawbacks of this course of treatment. Four databases were searched electronically without regard to publication date or language. Grey literature searches and manual searches were also undertaken. Publications with sufficient clinical data on targeted therapy for odontogenic tumors were required to meet the criteria for eligibility. The analysis of the data was descriptive. A total of 15 papers comprising 17 cases (15 ameloblastomas and 2 ameloblastic carcinomas) were included. Numerous mutations were found, with BRAF V600E being most common. Dabrafenib was the most utilized drug in targeted therapy. Except for one case, the treatment reduced the size of the lesion (16/17 cases), showing promise. Most of the adverse events recorded were mild, such as skin issues, voice changes, abnormal hair texture, dry eyes, and systemic symptoms (e.g., fatigue, joint pain, and nausea). It is possible to reach the conclusion that targeted therapy for ameloblastoma and ameloblastic carcinoma may be a useful treatment strategy, based on the findings of the included studies.
- 1 May 2024
- Published by Wiley in Oral Diseases
- Vol. 30 (6) , 3571-3581
Targeted therapies in ameloblastomas and ameloblastic carcinoma—A systematic review
Targeted therapy has the potential to be used in the neoadjuvant setting for odontogenic tumors, reducing the morbidities associated with major surgery. In this regard, the aim of this study was to summarize the current evidence on the different forms of targeted therapy, effectiveness, and drawbacks of this course of treatment. Four databases were searched electronically without regard to publication date or language. Grey literature searches and manual searches were also undertaken. Publications with sufficient clinical data on targeted therapy for odontogenic tumors were required to meet the criteria for eligibility. The analysis of the data was descriptive. A total of 15 papers comprising 17 cases (15 ameloblastomas and 2 ameloblastic carcinomas) were included. Numerous mutations were found, with BRAF V600E being most common. Dabrafenib was the most utilized drug in targeted therapy. Except for one case, the treatment reduced the size of the lesion (16/17 cases), showing promise. Most of the adverse events recorded were mild, such as skin issues, voice changes, abnormal hair texture, dry eyes, and systemic symptoms (e.g., fatigue, joint pain, and nausea). It is possible to reach the conclusion that targeted therapy for ameloblastoma and ameloblastic carcinoma may be a useful treatment strategy, based on the findings of the included studies.
- 1 February 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (2) , 167-176
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study
Purpose: The prognostic importance of RET and RAS mutations and their relationship to clinicopathologic parameters and outcomes in medullary thyroid carcinoma (MTC) needs to be clarified. Experimental design: A multicenter retrospective cohort study was performed utilizing data from 290 patients with MTC. The molecular profile was determined and associations were examined with clinicopathologic data and outcomes. Results: RET germline mutations were detected in 40 patients (16.3%). Somatic RET and RAS mutations occurred in 135 (46.9%) and 57 (19.8%) patients respectively. RETM918T was the most common somatic RET mutation (n=75). RET somatic mutations were associated with male sex, larger tumor size, advanced AJCC stage, vascular invasion (VI), and high IMTCGS grade. When compared with other RET somatic mutations, RETM918T was associated with younger age, AJCC (8th edition) IV, vascular invasion, extrathyroidal extension, and positive margins. RET somatic or germline mutations were significantly associated with reduced distant metastasis free survival on univariate analysis but there were no significant independent associations on multivariable analysis, after adjusting for tumor grade and stage. There were no significant differences in outcomes between RET somatic and RET germline mutations, or between RETM918T and other RET mutations. Other recurrent molecular alterations included TP53 (4.2%), ARID2 (2.9%), SETD2 (2.9%), KMT2A (2.9%), and KMT2C (2.9%). Among them, TP53 mutations were associated with decreased overall and disease-specific survival, independently of tumor grade and AJCC stage. Conclusions: RET somatic mutations were associated with high-grade, aggressive primary tumor characteristics, and decreased distant metastatic-free survival but this relationship was not significant after accounting for tumor grade and disease stage . RETM918T was associated with aggressive primary tumors but was not independently associated with clinical outcomes. TP53 mutation may represent an adverse molecular event associated with decreased overall and disease-specific survival in MTC but its prognostic value needs to be confirmed in future studies.
- 1 February 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (2) , 167-176
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study
Purpose: The prognostic importance of RET and RAS mutations and their relationship to clinicopathologic parameters and outcomes in medullary thyroid carcinoma (MTC) needs to be clarified. Experimental design: A multicenter retrospective cohort study was performed utilizing data from 290 patients with MTC. The molecular profile was determined and associations were examined with clinicopathologic data and outcomes. Results: RET germline mutations were detected in 40 patients (16.3%). Somatic RET and RAS mutations occurred in 135 (46.9%) and 57 (19.8%) patients respectively. RETM918T was the most common somatic RET mutation (n=75). RET somatic mutations were associated with male sex, larger tumor size, advanced AJCC stage, vascular invasion (VI), and high IMTCGS grade. When compared with other RET somatic mutations, RETM918T was associated with younger age, AJCC (8th edition) IV, vascular invasion, extrathyroidal extension, and positive margins. RET somatic or germline mutations were significantly associated with reduced distant metastasis free survival on univariate analysis but there were no significant independent associations on multivariable analysis, after adjusting for tumor grade and stage. There were no significant differences in outcomes between RET somatic and RET germline mutations, or between RETM918T and other RET mutations. Other recurrent molecular alterations included TP53 (4.2%), ARID2 (2.9%), SETD2 (2.9%), KMT2A (2.9%), and KMT2C (2.9%). Among them, TP53 mutations were associated with decreased overall and disease-specific survival, independently of tumor grade and AJCC stage. Conclusions: RET somatic mutations were associated with high-grade, aggressive primary tumor characteristics, and decreased distant metastatic-free survival but this relationship was not significant after accounting for tumor grade and disease stage . RETM918T was associated with aggressive primary tumors but was not independently associated with clinical outcomes. TP53 mutation may represent an adverse molecular event associated with decreased overall and disease-specific survival in MTC but its prognostic value needs to be confirmed in future studies.
- 13 July 2023
- Published by Springer Nature
- p. 209-269
Head and Neck Pathology
- 7 July 2023
- Published by Springer Nature in Head and Neck Pathology
- Vol. 17 (3) , 673-678
Verruciform Xanthoma: Clinical and Morphologic Spectrum Across Oral, Genital, and Cutaneous Sites
Background Verruciform xanthoma (VX) is an uncommon, benign epithelial lesion of the oral mucosa. While this entity can also present extraorally, including on the skin and in anogenital areas, the variation in its histologic features in extraoral sites is not yet well defined. Differences in the demographics and morphologic features of oral versus extraoral VX were assessed to help facilitate the accurate diagnosis and management of this lesion. Methods After obtaining IRB approval, 110 cases of diagnosed VX were retrospectively collected from our institutional archives spanning from 2000 to 2022. Patient age, gender, available medical history, lesion appearance, and duration were obtained for each case. Results The median age was 55 years (range 13–86) with a male-to-female ratio of 1.2:1. The most common oral sites, in descending order, were the palate (n = 24, 22%), buccal mucosa (n = 18, 16%), gingiva (n = 16, 15%), and tongue (n = 13, 12%). Extraoral sites comprised 9% of all lesions, including the scrotum (9), vulva (2), cheek (1), wrist (1), gluteal region (1), and abdominal wall (1). The median size for all lesions was 6.0 mm, and extraoral lesions were associated with a 6.7 mm larger size compared to oral lesions (B ± SE: 6.7 ± 2.5 cm, p = 0.01). The lesions were most frequently pink or white in color and often described as papillary, pedunculated, verrucous, and/or exophytic. Microscopically, the presence of wedge-shaped parakeratosis, keratin projections above the epithelium/epidermis, and associated inflammation significantly differed between oral and extraoral lesions. Prominent wedge-shaped parakeratosis (p = 0.04) and keratin projections above the epithelium/epidermis (p < 0.001) were more prevalent in extraoral lesions. There was no significant link between keratin projections and epithelial atypia (p = 0.44). Conclusions Familiarity with the broad morphological spectrum of VX, including the presence and degree of wedge-shaped parakeratosis, keratin projections above the epithelium/epidermis, and associated underlying inflammation, will be helpful in diagnosing it in unusual locations.
- 7 July 2023
- Published by Springer Nature in Head and Neck Pathology
- Vol. 17 (3) , 673-678
Verruciform Xanthoma: Clinical and Morphologic Spectrum Across Oral, Genital, and Cutaneous Sites
Background Verruciform xanthoma (VX) is an uncommon, benign epithelial lesion of the oral mucosa. While this entity can also present extraorally, including on the skin and in anogenital areas, the variation in its histologic features in extraoral sites is not yet well defined. Differences in the demographics and morphologic features of oral versus extraoral VX were assessed to help facilitate the accurate diagnosis and management of this lesion. Methods After obtaining IRB approval, 110 cases of diagnosed VX were retrospectively collected from our institutional archives spanning from 2000 to 2022. Patient age, gender, available medical history, lesion appearance, and duration were obtained for each case. Results The median age was 55 years (range 13–86) with a male-to-female ratio of 1.2:1. The most common oral sites, in descending order, were the palate (n = 24, 22%), buccal mucosa (n = 18, 16%), gingiva (n = 16, 15%), and tongue (n = 13, 12%). Extraoral sites comprised 9% of all lesions, including the scrotum (9), vulva (2), cheek (1), wrist (1), gluteal region (1), and abdominal wall (1). The median size for all lesions was 6.0 mm, and extraoral lesions were associated with a 6.7 mm larger size compared to oral lesions (B ± SE: 6.7 ± 2.5 cm, p = 0.01). The lesions were most frequently pink or white in color and often described as papillary, pedunculated, verrucous, and/or exophytic. Microscopically, the presence of wedge-shaped parakeratosis, keratin projections above the epithelium/epidermis, and associated inflammation significantly differed between oral and extraoral lesions. Prominent wedge-shaped parakeratosis (p = 0.04) and keratin projections above the epithelium/epidermis (p < 0.001) were more prevalent in extraoral lesions. There was no significant link between keratin projections and epithelial atypia (p = 0.44). Conclusions Familiarity with the broad morphological spectrum of VX, including the presence and degree of wedge-shaped parakeratosis, keratin projections above the epithelium/epidermis, and associated underlying inflammation, will be helpful in diagnosing it in unusual locations.